Verax Biomedical

Skip to content

News

09-26-2008
Verax Biomedical Platelet PGD® Test for Bacterial Detection Now CE Marked
10-18-2007
Verax Biomedical Receives ISO Certification
09-19-2007
Verax Biomedical Receives 510 (k) Clearance from FDA for Platelet PGD Test
06-15-2007
Verax Biomedical to Present at Annual ISBT Symposium
05-08-2007
Verax Biomedical Appoints Scott McKenzie and Nancy Hornbaker
03-14-2007
Verax Biomedical Submits 510(k) Application to FDA for Platelet PGD Test
01-29-2007
Verax Biomedical Appoints James Koziarz, Ph.D. to Board of Directors
12-18-2006
Verax Biomedical Taps British Biocell to Manufacture Platelet PGD Tests
10-20-2006
Abbott Signs Exclusive Worldwide Distribution Agreement With Verax Biomedical for Rapid Platelet Bacteria Test
09-28-2006
Verax Biomedical Initiates Two External Clinical Trials
09-05-2006
Verax Biomedical Names Chief Executive Officer
10-14-2005
Verax Biomedical Closes $15 Million Series B Private Placement

The PGD testing system

The Company's first product is the Platelet PGD Test — a rapid QC test for the detection of bacterial contamination in platelets.

Learn More